North America Human Microbiome Market

The report "North America Human Microbiome Market By Drug & Supplement (Drugs, Probiotics, Prebiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Diseases), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031" The North America human microbiome market is expected to reach USD 4.15 billion in 2031 from USD 0.78 billion in 2025, at a CAGR of 32.2% during the forecast period.

Browse 414 market data Tables and 50 Figures spread through 375 Pages and in-depth TOC on "North America Human Microbiome Market By Drug & Supplement (Drugs, Probiotics, Prebiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Diseases), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/north-america-human-microbiome-market-268083046.html

Postbiotics are emerging as a significant growth area in the North America human microbiome market. These are metabolites and cell components produced by probiotics, and they are gaining attention for their apparent health benefits and wider use in consumer and therapeutic products. Ongoing research is expanding the study of postbiotics in microbiome-based treatments, driving increased R&D activity, investment, and product development in the region. However, commercializing microbiome products and including postbiotics remains challenging. Regulatory pathways in the US and Canada are still evolving and can be complex. These factors may slow down market growth despite the rising interest and scientific progress in this field.

By type, the live bacteria products segment accounted for the largest share of the market in 2024.

By type, the North America Human Microbiome Market is segmented into bacterial consortia transplantation (BCT)/fecal microbiota transplantation (FMT), live bacteria products, and other types. In 2024, live bacteria products, which include probiotics and synbiotics, held the largest market share. Their strong position is driven by high consumer demand for digestive and immune health solutions and increasing clinical evidence supporting specific bacterial strains. Live bacteria products also move through formulation, regulatory, and distribution pathways more easily than more complex microbiome therapies, helping them reach the market faster. The growing interest in personalized nutrition, preventive health, and targeted microbiome interventions is further driving demand for these products.

By end users, the hospitals & clinics segment accounted for the largest share of the market in 2024.

End users segment the North America Human Microbiome Market into hospitals & clinics, long-term care facilities, and other end users. In 2024, hospitals and clinics held the largest share, and the leading position of this segment is attributed to their key role in delivering and managing microbiome-based therapies, especially for infectious and gastrointestinal conditions. FDA-approved products, such as VOWST and Rebyota, are primarily prescribed and administered in clinical settings under medical supervision. Hospitals and clinics also have the necessary infrastructure for handling live biotherapeutic products, including cold-chain systems, controlled storage, and patient monitoring. Additionally, these facilities play a central role in clinical research. They support patient recruitment, collect real-world evidence, and track outcomes, which are essential for advancing microbiome science and regulatory approvals.

By country, the US accounted for the largest share of the market in 2024.

In 2024, the US held the largest share of the North America human microbiome market. This is driven by its strong biotech ecosystem, advanced R&D capabilities, and active focus on microbiome science. The FDA approval of the first microbiome-based therapies for recurrent C. difficile infection has also accelerated investment in microbiome drugs, consumer health products, and next-generation therapies. The US market exhibits a high adoption of probiotics, prebiotics, and synbiotics, supported by growing consumer interest in gut health, immunity, and preventive care. High healthcare spending, strong innovation funding, and clearer regulatory pathways further support industry growth. Together, these factors make the US the largest and most influential market for human microbiome products in North America.

Some of the leading players in the market include Seres Therapeutics (US), Seed Health, Inc. (US), International Flavors & Fragrances Inc. (US), Pendulum (US), Biohm Technologies (US), Resbiotic (US), Infinant Health Inc. (US), and ExeGi Pharma (US), among others.

Don’t miss out on business opportunities in North America Human Microbiome Market . Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/